6:28 PM
 | 
Jan 26, 2015
 |  BC Extra  |  Politics & Policy

CMS to discuss prognostic tests for cancer

CMS's Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) will meet on March 24 to discuss molecular pathology tests for the prognosis of colorectal, breast and non-small cell lung cancer (NSCLC). The committee will review existing evidence that CMS may use to determine coverage for prognostic tests for cancer.

MEDCAC will consider...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >